Cruzan v. Director, Missouri Department of Health is a foundational U.S. Supreme Court case decided in 1990 (497 U.S. 261). The dispute centered on whether life-sustaining medical treatment could be withdrawn for a patient who lacked capacity and how much proof states may demand before allowing such an action. The decision shaped the legal landscape for end-of-life choices, advance directives, and medical ethics in the United States. Case citation and the Court's role are often consulted in discussions of constitutional limits and health law. Supreme Court context

The facts involved Nancy Cruzan, who had suffered catastrophic brain injury and was judged to be in a persistent vegetative state. Her family sought removal of the feeding tube that provided artificial nutrition and hydration, arguing that she would not have wanted continued life-prolonging care in that condition. Hospital staff declined to stop the tube without judicial authorization. The matter proceeded through Missouri courts and ultimately reached the U.S. Supreme Court. Readers seeking background on clinical terms may consult resources about persistent vegetative state. Vegetative state

The legal issues included whether the Constitution protects a right to refuse life-sustaining treatment for an incompetent person through a surrogate, and what evidentiary standard a state may impose. In a plurality opinion, the Court recognized that competent individuals have a constitutionally protected interest in refusing unwanted medical treatment but held that states may require clear and convincing proof of a patient's wishes before allowing withdrawal when the patient is incompetent. The ruling permitted states to insist upon a formal process or judicial oversight. The concept of a court order in such disputes is often referenced in later cases. Court order

The Court's explanation emphasized due process balancing: protecting individual autonomy while guarding against erroneous decisions that would end life. The decision did not establish a single national standard for evidence; instead it allowed state regulation to set higher proof requirements when a patient cannot speak for themselves. The phrase "clear and convincing evidence" from the opinion remains a central legal standard in many jurisdictions dealing with withdrawal of treatment. Clear and convincing evidence

Consequences and significance

  • After Cruzan, many states expanded or clarified laws on living wills, durable powers of attorney for health care, and advance directives so a patient's preferences would be documented in advance.
  • The ruling intensified public debate over the "right to die," influencing clinical practice, bioethics, and legislation. Advocates and critics invoked the decision when discussing terminal care and patient autonomy. Right-to-die issues
  • Cruzan prompted hospitals and clinicians to develop clearer policies about surrogate decision-making and procedural safeguards when patients lack capacity.

While the case did not resolve every moral or legal question about end-of-life care, it established an important precedent: states can require robust evidence before permitting removal of life-sustaining treatment for an incompetent person, and individuals are encouraged to use advance directives to ensure their wishes are honored. For further reading, scholars and practitioners often review the Court's opinion alongside state statutes and subsequent cases that refined the balance between autonomy and protection in end-of-life decisions. Case documents and analyses remain widely cited.